← Back to Patent Explorer
US4029642A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the manufacture of human insulin

Assignee: Hoechst AG
•
Filing: 1975-12-19
•
Granted: 1977-06-14
•
Expires: 1995-12-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for the manufacture of human insulin by the condensation of porcine des-B 23-30 octapeptide insulin with a peptide and subsequent splitting-off of the protective groups by treatment with trifluoroacetic acid or with alkali.

Inventors

  • 👤 Rainer Obermeier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 10:10
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/62; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/26

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 77 words
A method for making human insulin, which comprises condensing des-B 23-30 -octapeptide porcine insulin of the formula ##STR3## wherein R is an amino-protective group which is tert.-butyloxy-carbonyl, tert.-amyloxy-carbonyl, or methylsulfonyl-ethyloxy-carbonyl with a peptide of the formula H--Gly--Phe--Phe--Tyr(X)--Thr(X)--Pro--Lys(BOC)--Thr(Bu.sup.t)OBu.sup.t, wherein X is hydrogen or tert.-butyl, in the presence of dicyclohexyl carbodiimide and hydroxybenzotriazole, and then splitting off said amino-protective group with alkali if said group is methylsulfonyl-ethyloxy-carbonyl or with trifluoroacetic acid if said protective group is tert.-butyloxy-carbonyl or tert.-amyloxy-carbonyl.
Claim 2
Independent Claim 77 words
A method for making human insulin, which comprises condensing des-B 23-30 -octapeptide porcine insulin of the formula ##STR3## wherein R is an amino-protective group which is tert.-butyloxy-carbonyl, tert.-amyloxy-carbonyl, or methylsulfonyl-ethyloxy-carbonyl with a peptide of the formula H--Gly--Phe--Phe--Tyr(X)--Thr(X)--Pro--Lys(BOC)--Thr(Bu.sup.t)OBu.sup.t, wherein X is hydrogen or tert.-butyl, in the presence of dicyclohexyl carbodiimide and hydroxybenzotriazole, and then splitting off said amino-protective group with alkali if said group is methylsulfonyl-ethyloxy-carbonyl or with trifluoroacetic acid if said protective group is tert.-butyloxy-carbonyl or tert.-amyloxy-carbonyl.

References Cited (Backward Citations)

US3903068A Cited
US3847892A Cited
US3907765A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-06-13 1980-12-13 1981-06-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-06-13 1984-12-13 1985-06-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-06-13 1988-12-13 1989-06-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag